T50.A12D Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, subsequent encounter

Name of the Condition

• Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, subsequent encounter

Summary

This condition describes intentional self-harm poisoning resulting from exposure to a pertussis vaccine, either alone or in combination with other vaccine components, during a subsequent medical encounter following the event. Clinical presentation and management depend on the nature of the exposure and the patient's response.

Causes

Intentional self-harm poisoning may occur due to deliberate ingestion, injection, or other forms of exposure to pertussis vaccine. The pertussis vaccine component, such as inactivated or acellular antigens, is the primary agent involved in the toxic or adverse reaction.

Risk Factors

• History of intentional self-harm behaviors
• Access to vaccine materials
• Underlying mental health conditions
• Prior adverse reactions to pertussis vaccines

Symptoms

• Local reactions: swelling, redness, or pain at the injection site
• Systemic reactions: fever, irritability, or malaise
• Allergic responses: rash, urticaria, or anaphylaxis
• Neurological symptoms: dizziness, confusion, or seizures

Diagnosis

Diagnosis is based on a history of intentional vaccine exposure, clinical evaluation of symptoms, and exclusion of other causes. Laboratory tests or allergist consultation may be used to assess severity.

Treatment Options

Management focuses on stabilizing the patient, addressing symptoms, and providing supportive care. This may include antihistamines for allergic reactions, monitoring for respiratory distress, or psychiatric evaluation for self-harm risk.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure and timely intervention. Follow-up care may involve monitoring for delayed reactions, assessing mental health needs, and ensuring adherence to safety measures.

Complications

• Severe allergic reactions (e.g., anaphylaxis)
• Respiratory distress or failure
• Neurological damage from toxic exposure
• Psychological complications related to self-harm

Lifestyle & Prevention

• Secure storage of vaccines to prevent access
• Education on safe vaccine handling
• Mental health support for individuals at risk of self-harm
• Regular psychiatric evaluations for high-risk patients

When to Seek Professional Help

Seek immediate medical attention if symptoms like difficulty breathing, severe swelling, or altered consciousness occur. Prompt care is critical for managing toxic or allergic reactions.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (subsequent) clearly. Ensure clinical notes specify the vaccine involved and the nature of the exposure to support accurate coding.